Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May;8(5):865-7.
doi: 10.1111/j.1538-7836.2010.03832.x. Epub 2010 Mar 3.

Platelet polyphosphate: an endogenous activator of coagulation factor XII

Affiliations

Platelet polyphosphate: an endogenous activator of coagulation factor XII

N Mackman et al. J Thromb Haemost. 2010 May.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Different ways to activate the clotting cascade. The extrinsic pathway consists of TF and FVII/VIIa (orange) and is activated by either vascular injury or by TF expression within the vasculature. The intrinsic pathway consists of FXII, FXI, FIX and FVIII (turquoise) and is activated at various levels by polyP, thrombin and TF-FVIIa. The common pathway consists of FV and FX, and prothrombin (II) (pink). Finally, fibrin is converted into cross-linked fibrin by FXIIIa. Platelets (Plt) contribute to the clotting cascade by releasing polyP, which activates FXII, and by providing a surface for the assembly of the different complexes, such as the intrinsic tenase complex (FVIIIa–FIXa) and the prothrombinase complex (FVa–FXa). The clotting cascade can be activated by the generation of small amounts of thrombin via either the extrinsic pathway (TF-FVIIa to FXa or TF-FVIIa to FIXa to FXa), or via the intrinsic pathway (FXIIa to FXIa to FIXa to FXa). The propagation phase involves the generation of large amounts of thrombin by the prothrombinase complex (FVa–FXa). PolyP also modulates coagulation by accelerating the activation of FV and by enhancing fibrin polymerization.

Similar articles

Cited by

References

    1. Macfarlane RG. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature. 1964;202:498–9. - PubMed
    1. Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science. 1964;145:1310–2. - PubMed
    1. Broze GJ. Tissue factor pathway inhibitor. Thromb Haemost. 1995;74:90–3. - PubMed
    1. Ratnoff OD, Colopy JE. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest. 1955;34:602–13. - PMC - PubMed
    1. Pauer HU, Renné T, Hemmerlein B, Legler T, Fritzlar S, Adham I, Müller-Esterl W, Emons G, Sancken U, Engel W, Burfeind P. Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo. Thromb Haemost. 2004;92:503–8. - PubMed

Publication types